Health
CSOFT’s health blog aims to provide insight into complex diseases, treatment options and regulatory developments, and other prevalent health issues people face today.Empowering Community Health: Previewing Joslin’s Ginger Forum 2024 with CSOFT Health Sciences
The Joslin Diabetes Center Asian American Diabetes Initiative’s (AADI) Ginger Forum 2024 is uniting healthcare leaders, researchers, and advocates to advance culturally tailored, collaborative, and localized strategies for diabetes prevention and management. On...
The Complexities of Linguistic Validation for Licensed COAs in Global Clinical Trials
Linguistic validation is a process of translating, reviewing and validating the accuracy, reliability, and conceptual equivalency for patient reported clinical outcome assessments (COAs). CSOFT Health Sciences manages the entire life cycle of an extended process of...
Optimizing Global Patient Recruitment with Localization Solutions for Clinical Trials
The world of clinical trials, global patient recruitment is a persistent challenge. Studies show that nearly 55% of clinical trials fail to meet their original recruitment targets, and about 30% of participants drop out before completing the trial. The diversity of...
Bridging the Gap in Rare Disease Clinical Trials
In rare disease research, the stakes are uniquely high. With over 7,000 identified rare diseases and millions of people affected worldwide, finding effective treatments often feels like a race against time. Yet the very nature of rare diseases presents a daunting...
Dr. Frank Hu at CSOFT Summer Soiree 2024: Ultimate Health Vision
At our 2024 Summer Soiree, CSOFT had the privilege of hosting Dr. Frank Hu, a distinguished guest at the event. Dr. Frank Hu, a Fredrick J. Stare Professor of Nutrition and Epidemiology at the Harvard T.H. Chan School of Public Health and Professor of Medicine at...
Understanding the Importance of Localization in Global Clinical Trials from Protocol to Patient
In an era of unprecedented connectivity, clinical trials have evolved far beyond the confines of a single country or region. Today, global clinical trials are the cornerstone of modern drug development, encompassing multiple continents and engaging a broad spectrum of...
Translation and Localization for Pharmacovigilance
Pharmacovigilance (PV) is crucial in the pharmaceutical industry, focusing on detecting, assessing, understanding, and preventing adverse effects or other drug-related health risks. The primary goal of PV is to improve patient care and safety about the use of...
Breaking Barriers in Preventative Healthcare Through Localization
In today's rapidly evolving global healthcare landscape, prioritizing preventative measures has become imperative amid the rising prevalence of chronic diseases. Preventative healthcare strategies, aimed at anticipating health issues rather than merely reacting to...
Empowering Community Health at the Massachusetts Asian American Diabetes Summit
The Massachusetts Asian American Diabetes Summit recently took place, addressing the specific needs of Asian American communities in Eastern Massachusetts concerning diabetes prevention and treatment. This significant event was held in May, a month dedicated to...
CSOFT Health Sciences at DIA 2024: Leading the Way in Patient Diversity and Innovative Solutions
We are excited to announce that CSOFT Health Sciences will be participating in the DIA 2024 Global Annual Meeting this June. This prestigious event provides us with a great opportunity to demonstrate our dedication to advancing the life sciences industry, especially...
Categories
ABOUT US
CSOFT Health Sciences has over 15 years of experience providing end-to-end translation and localization solutions for all stages of the product life cycle, from pre-clinical to post-launch. We also specialize in China market access consulting services, Asian regulatory and eCTD submissions. Our operation is compliant with ISO 17100 and certified by BSI in ISO 9001:2015 and ISO 13485:2016, providing customized solutions to meet the rigorous regulatory requirements in global submission. For more information, please visit: www.csoftintl.com